AZN
NYSE AstraZeneca PLC$158.33 ↑ +0.00 (+0.00%) Trading Up from the previous close of $158.33, $1.11 below the day’s high of $159.44
- YTD change
- +72.23%
- vs 20-day SMA
- -2.61%
- vs 200-day SMA
- -6.55%
Price ranges
Price & Performance
-43.91 (-21.71%) / 6M
Signals & Sentiment
Momentum, market sentiment, and recent alerts
- The stock is 25.6% away from all-time highs of $212.71
- AZN is up 72% since the beginning of the year
- AZN is up 87% over the past 12 months
- AZN is down 1% over the past 1 month
- 0% of all AZN investors are betting against AZN
- Number of investors short AZN has gone down 10% versus last month
AZN reads not so good: price sits below both the 20- and 200-day averages, short interest is falling month over month, the 12-month move is +87.4%.
- Previous minute
- +$0.00
- Last hour
- +$0.30
- Last 5 days
- +0.91%
- vs 8-day SMA
- -0.21%
Financial Strength
Earnings, valuation, and balance sheet
Earnings
Valuation
Balance sheet & scale
Company & Peers
Company profile and competitor comparison
Company profile
AstraZeneca Plc is a global, science-led biopharmaceutical company focused on the discovery, development, and commercialization of prescription medicines. Its portfolio spans oncology, rare diseases, and biopharmaceuticals, including cardiovascular, renal & metabolism, and respiratory & immunology. The company was founded in 1913 and is headquartered in Cambridge, the United Kingdom.
You looked up one stock
Trade Ideas watches them all
Real-time scanning and AI-generated signals across the entire market.
Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.